Purpose: The purpose of this work was to assess SSA from Luminex as a Salmonella serotype identification tool in comparison to traditional serotyping using antisera.
Methods: One hundred twenty-four Salmonella isolates were used in this study. All samples were prepared for analysis following the manufacturer’s protocol and screened with the Luminex assay. Data was analyzed and entered into the Luminex software tool to determine the serotype or candidate serotypes. The identities of these isolates were also determined by traditional serotyping.
Results: SSA results agreed with the antisera result for 60 isolates (48%). An additional 51 isolates (41%) were partially matched but required further analysis of single factors (due in part to several factors not being included in assay). Thirteen isolates (11%) results did not match antisera result.
Significance: The SSA can fully serotype 80 of the top 100 clinically-associated serotypes. However, SSA capability of partial serotyping, thus lowering the number of agglutination assays required to determine identity, could make it an option for molecular-based serotyping of Salmonella.